ArticleNPJ genomic medicine2018

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin.

Pedro Torres-Ayuso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.